Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Flexus Biosciences Inc.

Headquarters: San Carlos, CA, United States of America
Website: N/A
Year Founded: 2013
Status: Acquired

BioCentury | Aug 18, 2017
Company News

Arcus gets rights to PD-1 mAb from WuXi, Gloria

BioCentury | Aug 17, 2017
Company News

Arcus gets rights to PD-1 mAb from WuXi, Gloria

BioCentury | Aug 10, 2017
Emerging Company Profile

Flexing against suppression

FLX Bio aims to selectively stop immune suppressors in cancer
BioCentury | Apr 12, 2017
Clinical News

BMS-986205: Ph I/IIa data

BioCentury | Apr 7, 2017
Finance

To market, to market

Investors watching for new approvals and cancer, Orphan data in 2Q17
BioCentury | Aug 29, 2016
Financial News

Arcus discloses $119.7M in financings

BioCentury | May 2, 2016
Finance

Flexus redux

Why Flexus' VCs are back for seconds with cancer company FLX
Items per page:
1 - 10 of 24